SCHEMBL14101674

SCHEMBL14101674

c1ccc(-c2ccc3sc4ccc(-c5ccc6ccc7cccc8ccc5c6c78)cc4c3c2)c(-c2ccc3sc4ccc(-c5ccc6ccc7cccc8ccc5c6c78)cc4c3c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.41
ERBB2 P04626 1/20 0.41
FYN P06241 1/20 0.41
MAOA P21397 1/20 0.41
ACHE P22303 1/20 0.41
AHR P35869 1/20 0.41
S1PR5 Q9H228 8/20 0.38
S1PR4 O95977 6/20 0.38
ALDH1A1 P00352 5/20 0.36
HSD17B10 Q99714 5/20 0.36
HPGD P15428 4/20 0.36
THRB P10828 1/20 0.36
TSHR P16473 4/20 0.36
CYP3A4 P08684 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
F9 P00740 1/20 0.35
ALOX5 P09917 1/20 0.35
MAPK1 P28482 2/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101532 0.96 F9 (0.42) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL14101428 0.95 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL14101523 0.94 CYP1A2 (0.42) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL14101454 0.94 CYP1A2 (0.45) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL14101461 0.94 CYP1A2 (0.45) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL14101449 0.94 CYP1A2 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL14101662 0.94 CYP1A2 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL14101669 0.94 CYP1A2 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL14101515 0.93 CYP1A2 (0.45) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL14101518 0.93 ALDH1A1 (0.41) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, BPNT1, TYR CYP1A2 232/4885ERBB2 3074/4885FYN 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.